Joseph Olobo - Concepedia

Author

Joseph Olobo

Also Known As

J O Olobo, J Olobo, J. O. OLOBO, J. O. Olobo, J.O Olobo, J.O. Olobo, Joseph O Olobo, Joseph O. Olobo, Joseph Okao Olobo, Joseph Olobo

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Kenya Medical Research Institute Makerere University Institute of Primate Research Drugs for Neglected Diseases Initiative National Museums of Kenya

About

Joseph Olobo is an author at Kenya Medical Research Institute specializing in parasitology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	14	335
2	Natural Sciences	2	2	31
3	Public Health	1	1	26
4	Allergy	1	1	10
5	Biochemistry	1	1	20

Joseph Olobo

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Human T Cell Responses to the ESAT‐6 Antigen from<i>Mycobacterium tuberculosis</i> Pernille Ravn, Abebech Demissie, Tewodros Eguale, The Journal of Infectious Diseases	1999	301
Immune Responses to the <i>Mycobacterium tuberculosis</i> -Specific Antigen ESAT-6 Signal Subclinical Infection among Contacts of Tuberculosis Patients T. Mark Doherty, Abebech Demissie, Joseph Olobo, Journal of Clinical Microbiology	2002	250
Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial Ahmed Musa, Eltahir Awad Gasim Khalil, Asrat Hailu, PLoS neglected tropical diseases	2012	168
Identification of the Causative Organism of Tuberculous Lymphadenitis in Ethiopia by PCR Dawit Kidane, Joseph Olobo, Abebe Habte, Journal of Clinical Microbiology	2002	125
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial Monique Wasunna, Simon Njenga, Manica Balasegaram, PLoS neglected tropical diseases	2016	103
Circulating TNF‐α, TGF‐β, and IL‐10 in Tuberculosis Patients and Healthy Contacts Joseph Olobo, Mulu Geletu, Abebech Demissie, Scandinavian Journal of Immunology	2001	100
Vervet Monkeys Vaccinated with Killed<i>Leishmania major</i>Parasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected against Challenge Infection Michael M. Gicheru, Joseph Olobo, Christopher O. Anjili, Infection and Immunity	2001	79
T-Cell Recognition of<i>Mycobacterium tuberculosis</i>Culture Filtrate Fractions in Tuberculosis Patients and Their Household Contacts Abebech Demissie, Pernille Ravn, Joseph Olobo, Infection and Immunity	1999	68
Vaccination of vervet monkeys against cutaneous leishmaniosis using recombinant Leishmania ‘major surface glycoprotein’ (gp63) Joseph Olobo, C. O. Anjili, Michael M. Gicheru, Veterinary Parasitology VaccinationVeterinary VaccineVaccine DevelopmentParasitic ProtozoaImmunology	1995	65
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial Ahmed Musa, Jane Mbui, Rezika Mohammed, Clinical Infectious Diseases	2022	64

Page 1